Crypto Blockchain Industries (ALCBI) Fair Value & Analysis
Financial Services · FR · Market cap €22.0M
Fair value as of: Jun 25, 2026
Analysis
Crypto Blockchain Industries (ALCBI) currently trades at €0.0918, while our model-based Fair Value estimate is €0.0800 — implying the stock looks roughly 12.9% overvalued today. We read business quality at 94/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Crypto Blockchain Industries engages in the cryptocurrency and blockchain-based application business in France. The company engages in the purchase of cryptocurrencies, including Bitcoin and Solana on the market; and operation of Bitcoin mining business. It also develops proprietary Web3 platforms that integrate tokens for utility use, such as AlphaVerse, a modular metaverse connected by a central hub; Football at AlphaVerse, a football universe that utilizes tokens for microtransactions, discounts, community missions, and loyalty programs; HorYou AlphaVerse; and Gemplay, a platform that combines competitive games and real-life diamonds represented by NFTs. The company was incorporated in 2021 and is headquartered in Paris, France. Crypto Blockchain Industries operates as a subsidiary of Ker Ventures, Sarl.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Crypto Blockchain Industries (ALCBI) undervalued?
What is the fair value of ALCBI?
What is the quality score of ALCBI?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.